MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12032-009-9351-4

Медицинская библиотека · Medical oncology (Northwood, London, England) · 2009

The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.

Kim Seung Tae, Lee Jeeyun, Lee Kyu Taek, Lee Jong Kyun, Lee Kwang Hyuk, Choi Seong-Ho, Heo Jin-Seok, Choi Dong Wook, Park Se Hoon, Park Joon Oh, Lim Ho Yeong, Park Young Suk, Kang Won Ki

СтатьяПеревод пока не подготовлен

Аннотация

Adenocarcinoma arising from the ampulla of Vater is a rare neoplasm that accounts for only 0.2% of all gastrointestinal tract malignancies and has limited data regarding its frontline therapy. We investigated the treatment outcomes in patients with advanced adenocarcinoma of the ampulla of Vater receiving frontline cisplatin-based combination chemotherapy. We analyzed 29 patients with advanced adenocarcinoma of the ampulla of Vater who had been treated by frontline cisplatin-based combination chemotherapy between June 2003 and April 2008. The chemotherapeutic agent added to cisplatin was gemcitabine in 9 patients and fluorouracil (FU) in 20 patients (11; intravenous 5-FU and 9; oral 5-FU (capecitabine)). The median age of patients was 56 years (range, 36-78), and the median ECOG performance status was 1 (0-1). The confirmed overall response rate was 27.5%, and the disease control rate was 72.4%. In all patients, no complete responses and 8 partial responses were observed (overall response rate, 27.5%). Stable disease was observed in 13 patients (44.8%), and progressive disease in 5 patients (17.2%). The median time to progression (TTP) was 4.9 months (95% CI, 3.4-6.4), and the median overall survival (OS) was 12.5 months (95% CI, 10.6-14.4). There were no significant differences for TTP and OS according to the different chemotherapeutic agents added to cisplatin. Grade 3 or 4 hematologic toxicities included leukopenia in seven patients and thrombocytopenia in one patient. There were no grade 3 or 4 nonhematologic toxicities or treatment-related deaths. The cisplatin-based combination chemotherapy showed moderate activity and a favorable toxicity profile as a frontline treatment for patients with advanced adenocarcinoma of the ampulla of Vater.

Для цитирования: Kim Seung Tae, Lee Jeeyun, Lee Kyu Taek, Lee Jong Kyun, Lee Kwang Hyuk, Choi Seong-Ho, Heo Jin-Seok, Choi Dong Wook, Park Se Hoon, Park Joon Oh, Lim Ho Yeong, Park Young Suk, Kang Won Ki. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.. Medical oncology (Northwood, London, England). 2009. DOI: 10.1007/s12032-009-9351-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.